Initial screening and retest mode in apheresis platelet donors: a comparative analysis
Journal Title: Chinese Journal of Blood Transfusion - Year 2023, Vol 36, Issue 3
Abstract
Objective To investigate the effectiveness of current indicators in initial screening and retest before donation and access the optimal testing strategies. Methods Data of initial screening (rate method for ALT, colloidal gold method for HBsAg) and retest (rate method for ALT, ELISA for HBsAg) of 18 510 platelet donors in our center from January 2019 to December 2021 were collected, and the results were retrospectively analyzed and compared in terms of different years and number of donations. Results From 2019 to 2021, data of initial screening and retest of platelet donors were as follows: 1) the deferral rate of ALT and HBsAg was 12.98% (2 403/18 510) vs 0.26%(40/15 412); 2) the deferral rate of ALT was 13.19% (712/5 398) vs 0.20%(9/4 410)in 2019, 13.33% (873/6 549) vs 0.06%(3/5 387)in 2020 and 11.05% (725/6 563) vs 0.07%(4/5 615)in 2021; for initial screening, significant difference was noticed in ALT reactivity in 2021 as in comparison to other two years(P<0.05); 3) the reactive rate of HBsAg was 0.43% (23/5 398) vs 0.18%(8/4 410)in 2019, 0.66% (43/6 549) vs 0.20%(11/5 387)in 2020 and 0.41% (27/6 563) vs 0.09%(5/5, 615) in 2021. For initial screening, HBsAg deferral in 2021 was significantly different from 2019, while similar with 2020. 4) Among ALT deferral samples in the retest, 68.75% (11/16) were ALT≥45 U/L. Among HBsAg reactive samples, 91.67% (22/24) were reactive by single reagent. Conclusion Setting the threshold value of ALT for platelet donors in initial screening as less than 45 U/L can effectively reduce the reactive rate in the retest. HBsAg screening only for first-time platelet donors can reduce the detection cost. Adding pre-donation detection indicators according to local prevalence of transfusion transmitted diseases is conductive to reduce the discarding rate of platelets.
Authors and Affiliations
Yuanfeng CHEN, Xiaoling WU, Aiping ZHAO
Keywords
Related Articles
- EP ID EP738502
- DOI 10.13303/j.cjbt.issn.1004-549x.2023.03.003
- Views 68
- Downloads 0
Analysis of risk factors in blood donors with confirmed positive syphilis
Objective To study the risk factors of blood donors confirmed to be positive for syphilis, so as to avoid highrisk groups, guide the recruitment of blood donors and improve blood safety. Methods From September 2021 to Au...
Clinical application of thrombelastogram and reference interval for our laboratory
Objective To respectively analyze the application of thrombogram (TEG) in our hospital and explore the reference interval for our laboratory. Methods Healthy adults who underwent physical examination in our hospital from...
Prediction of B cell epitopes of CD36 and preparation of MAP
Objective To analyze the structure of CD36, search the possible B cell epitopes and prepare multi-antigen peptides(MAP) with B cell epitopes, so as to provide a preliminary experimental basis for the preparation of CD36...
Diagnostic analysis and clinical treatment strategies for patients with hyperhemolytic syndrome: a case report
Objective To analyze a case of hyperhemolytic syndrome(HHS) and explore the laboratory diagnostic method and clinical treatment strategy. Methods Serological tests such as blood typing, direct antiglobulin test(DAT), ant...
Establishment of internal quality control methodology for blood transfusion compatibility testing
Objective To monitor the effectiveness and accuracy of the blood transfusion compatibility test system by self-made weakly positive internal quality control products. Methods Red blood cells from DAT(-) healthy subjects...